Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Approval of first interchangeable biosimilar insulin to increase competition with payer contracts:…
While patients will be increasingly prescribed Viatris/Biocon’s Semglee over Sanofi’s Lantus due to its competitive pricing,…
Indonesia authorises Sputnik V: RDIF
The total population of all countries where Sputnik V is approved for use now exceeds four billion people, which is more than half…
Vir Biotechnology announces maiden marketing authorisation for sotrovimab in Australia
As part of its overarching effort to address COVID-19, the Australian Government recently announced an agreement to purchase…
New Agilent InfinityLab Poroshell 120 preparative LC columns
Think you have to sacrifice speed to obtain confident answers to everyday research questions? Think again. The new Agilent…
New Agilent AdvanceBio Peptide Plus charged surface C18 columns
LC/MS analysis helps you accurately characterize therapeutic drugs to understand their structure.
AdvanceBio Peptide Plus columns…
Vertex and Arbor Biotechnologies partner to develop novel ex-vivo engineered cell therapies
Vertex to use Arbor’s CRISPR gene-editing technology to enhance efforts in developing novel cell therapies for the treatment of…
European Medicines Agency (EMA) grants Orphan Designation for AOC 1001
The FDA cleared Avidity to proceed with the phase-I/II Marinatm trial of AOC 1001 in adults with myotonic dystrophy type 1 (DM1)…
IVI and Bharat Biotech launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica
IVI is advancing clinical development of BBV87 through a phase-II/III randomised, controlled trial to evaluate the safety and…
India’s first COVID-19 mRNA vaccine developed in partnership with DBT-BIRAC
The Vaccine Subject Expert Committee (SEC) reviewed the interim phase-I data and found that HGCO19 was safe, tolerable and…
LANXESS to acquire IFF’s microbial control business
The transaction is still subject to approval by the relevant anti-trust authorities